A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+ T Cell Epitopes-Reference-Cited by-同舟云学术

A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+ T Cell Epitopes

Published:2021-02-19 Issue:3 Volume:15 Page:4357-4371
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

He Xuedan¹,Zhou Shiqi¹,Huang Wei-Chiao¹,Seffouh Amal²,Mabrouk Moustafa T.¹,Morgan M. Thomas³,Ortega Joaquin²,Abrams Scott I.⁴^ORCID,Lovell Jonathan F.¹^ORCID

Affiliation:

1. Department of Biomedical Engineering. University at Buffalo, State University of New York, Buffalo, New York 14260, United States

2. Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec H3A0C7, Canada

3. Raybow USA Inc., Brevard, North Carolina 28712, United States

4. Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.0c07680

Reference52 articles.

1. Trial watch: Peptide-based vaccines in anticancer therapy

2. Designer vaccine nanodiscs for personalized cancer immunotherapy

3. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma

4. Applications of viral nanoparticles in medicine

5. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective;Coordination Chemistry Reviews;2024-10

2. Rational Design of Lipid-Based Vectors for Advanced Therapeutic Vaccines;Vaccines;2024-05-31

3. Development of semisynthetic saponin immunostimulants;Medicinal Chemistry Research;2024-05-18

4. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine;Journal of Controlled Release;2024-05

5. CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits;Nature Communications;2024-04-11